Catherine Skari
-
Apr- 2026 -17 AprilNews
TIF STATEMENT | A Plea for the Untold Victims of Conflict
The purpose of this plea is not to repeat facts well known. Instead, we want this to act as a…
Read More » -
16 AprilCollaborating Centres
Guangzhou First People’s Hospital, China
The Department of Haematology at the Nansha Branch of Guangzhou First People’s Hospital, China, is part of one of Guangdong…
Read More » -
3 AprilNews
APLASTIC ANAEMIA | ASH Publishes Guidelines on Diagnosis and Management of Severe and Very Severe Disease
Aplastic anaemia is a rare disorder characterized by bone marrow failure and reduced production of blood cells, resulting in pancytopenia…
Read More » -
2 April
Kanexthal
Update: 31 March 2026 Results from the first 17 treated patients in an investigator-initiated trial (IIT) were announced in 2024…
Read More » -
Mar- 2026 -20 March
-
19 MarchNews
TIF WEBINAR SERIES 2026 | Bridging the Communication Gap in Haemoglobinopathy Care
This year, the Thalassaemia International Federation (TIF) launches a transformative quarterly webinar series designed to strengthen dialogue between patients, families,…
Read More » -
9 MarchNews
wAIHA | Rilzabrutinib Receives FDA Breakthrough Therapy Designation
Warm autoimmune haemolytic anaemia is a rare autoimmune disorder characterized by the premature destruction of red blood cells, leading to…
Read More » -
Feb- 2026 -20 February
-
14 FebruaryNews
RARE DISEASE DAY 2026 | More Than You Can Imagine
This year’s theme, “More Than You Can Imagine,” reminds us that rare diseases are far more common, complex, and impactful…
Read More » -
4 FebruaryNews
wAIHA | Sovleplenib Demonstrates Positive Phase III Clinical Results
wAIHA is a rare autoimmune disorder in which the immune system produces antibodies that mistakenly target and destroy red…
Read More »
